Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 10 October 2005. doi:10.1136/hrt.2005.068288
Heart 2006;92:585-588
Copyright © 2006 BMJ Publishing Group Ltd & British Cardiovascular Society

HEART REVIEW

The future of drug eluting stents

R R Anis, K R Karsch

Correspondence to:
Professor Karl R Karsch
Bristol Heart Institute, University of Bristol, Bristol BS2 8HW, UK; k.r.karsch{at}bristol.ac.uk

ABSTRACT

In-stent restenosis (ISR) is the major drawback of percutaneous coronary interventions, occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority of patients in preventing restenosis for the first year after implantation. Recently, new stents have emerged that are loaded with anti-inflammatory, antimigratory, antiproliferative, or pro-healing drugs. These drugs are supposed to inhibit inflammation and neointimal growth and subsequently ISR. The future of DES lies in the development of better stents with new stent designs, better polymers including biological polymers and biological biodissolvable stent coatings, and new, better drugs.

Abbreviations: DES, drug eluting stents; ENDEAVOR, randomised, controlled trial of the Medtronic Endeavor drug (ABT-578) eluting coronary stent system versus the Taxus paclitaxel-eluting coronary stent system in de novo native coronary artery lesions; EuroSTAR, European collaborators registry on stent-graft techniques for abdominal aortic aneurysm repair; ISR, in-stent restenosis; PC, phosphorylcholine coated; PCL, poly({varepsilon} caprolactone); PLGA, poly(DL-lactide-co-glycolide); RAVEL, randomized study with sirolimus coated BX velocity balloon expandable stent in the treatment of patients with de novo native coronary lesions; SIRIUS, sirolimus eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions; TAXUS, treatment of de novo coronary disease with a single paclitaxel eluting stent; VEGF-2, vascular endothelial growth factor 2

Keywords: drug eluting stents; review


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Heart Review series
Heart 2006 92: 7. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Bakhshi, R., Edirisinghe, M.J., Darbyshire, A., Ahmad, Z., Seifalian, A.M. (2009). Electrohydrodynamic Jetting Behaviour of Polyhedral Oligomeric Silsesquioxane Nanocomposite. J Biomater Appl 23: 293-309 [Abstract]  
  • Shoulders-Odom, B. (2008). Management of Patients After Percutaneous Coronary Interventions. Crit Care Nurse 28: 26-40 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.